SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.8200.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1063)2/3/1999 12:37:00 PM
From: Dan Spillane  Read Replies (2) of 2539
 
Gack! So Monsanto gets 80 percent of the revenue from Celebrex, and yet the houses upgrade PFIZER AND MERCK due to the success of Celebrex?!? Pfizer only gets 20 percent, Merck gets ZERO!

What a joke!

(from the story)
Our revenue estimates for the product are $650 million in 1999 and $900 million in 2000. Pfizer will book its share of profits in its Alliance Revenue line as it does for Lipitor and Aricept currently. We are assuming alliance revenue from Celebrex of $77 million and $113 million for 1999 and 2000, respectively.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext